Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2022-03-17 Annual Report
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2021
2022-03-17 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 17, 2022, reporting the results of operations for the fourth quarter and year ended December 31, 2021. It specifically mentions an attached earnings press release (Exhibit 99.1) reporting financial results. The text indicates this is an initial announcement of quarterly/year-end financial results, which aligns with the definition of an Earnings Release (ER). The document length is 3378 characters, which is relatively short and consistent with an earnings release announcement rather than a full annual or quarterly report. Therefore, the classification is Earnings Release (ER).
2022-03-17 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 14, 2022, reporting an event where the FDA intends to post a Medical Device Safety Communication related to the company's products. The document includes a press release as an exhibit. The content is an event notification rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial data. The document length is 3110 characters, which is relatively short and consistent with an event announcement. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-03-14 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-14 English
APYX MEDICAL CORPORATION
Major Shareholding Notification
2022-02-14 English
FORM 4
Director's Dealing
2022-02-01 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.